Search results for "SAGE"

showing 10 items of 1373 documents

Preparation and Biological Evaluation of Ethylcellulose Microspheres Containing Tolmetin

1992

AbstractTolmetin microspheres were prepared by the coacervation process from the ethylcellulose. Microspheres were obtained both in presence and without protecting colloids, such as polyisobutilene (PIB) or ethyl-vinylacetate copolimers (EVA). The effect of these agents on the preparation, drug content, wall thickness, surface morphology, drug dissolution arid release from microspheres, were evaluated. The dissolution rate analysis was carried out also in the presence of a surfactant (Tween 80) at different pH values.In addition, microspheres containing Tolmetin as a core material were submitted to biological tests, in comparison with the free drug, to evaluate upon experimental models the …

PharmacologyActive ingredientChromatographyCoacervateChemistryOrganic ChemistryPharmaceutical SciencePharmacologyDosage formPulmonary surfactantDrug DiscoverymedicineTolmetinDissolution testingAntipyreticDissolutionmedicine.drugDrug Development and Industrial Pharmacy
researchProduct

ComparativeIn Vitroevaluation of cumulative release of the urinary antiseptics Nalidixic acid, Pipemidic acid, Cinoxacin, and norfloxacin from white …

1994

AbstractThe in vitro diffusion of nalidixic acid (1), pipemidic acid (2), cinoxacin (3), and norfloxacin (4) was studied. The transfer rate constants (kd) from simulated gastro-intestinal juices to simulated plasma, throughout artificial wall lipid membranes, were defined. The kd values suggested that the four drugs are absorbed both in gastric and intestinal environments in similar amounts. To obtain lack of gastric unwanted effects white beeswax microspheres containing 1, 2, 3, and 4 were investigated as a vehicle for the drug intestinal release; they were prepared by the meltable dispersion process using wetting agents. Discrete, reproducible free flowing microspheres were obtained. The …

PharmacologyActive ingredientChromatographyNalidixic acidChemistryOrganic ChemistryCinoxacinPharmaceutical SciencePipemidic acidAbsorption (skin)Dosage formBiochemistryDrug DiscoverymedicineNorfloxacinmedicine.drugAntibacterial agentDrug Development and Industrial Pharmacy
researchProduct

Iontophoretic in Vitro Release of Antimycotics from Hydrogels

1993

A new in vitro model for iontophoretic release from hydrogels was developed. It represents a modification of the rotary disk cell developed by Moll/Bender and can be used in a normal dissolution tester. The iontophoretic release from antimycotic hydrogels through an artificial membrane was investigated and different types of antimycotics were tested. The influence of current density, drug concentration and vehicle was determined.

PharmacologyActive ingredientIontophoresisChemistryOrganic ChemistrySynthetic membranePharmaceutical SciencePharmacologyDosage formIn vitroIn vitro modelDrug DiscoverySelf-healing hydrogelsBiophysicsLiberationDrug Development and Industrial Pharmacy
researchProduct

Conditioning following powder micronization: influence on particle growth of salbutamol sulfate.

2003

Micronization is a high-energy process that induces changes in the crystallinity of materials. As a result, the crystalline structures on the particles' surface are being destroyed and amorphous areas are formed. After micronization of salbutamol sulfate to be used in dry powder inhalers, only small amounts of amorphous material are produced. Nevertheless, even these small amounts can have important effects on the physical stability of the powder. The amorphous state is thermodynamically unstable and tends to convert to the stable, crystalline state. The recrystallization process of disordered regions on the particles' surface leads to particle growth of milled particles. In this case, brid…

PharmacologyChromatographyMaterials scienceOrganic ChemistryPharmaceutical ScienceRecrystallization (metallurgy)Dosage formAmorphous solidlaw.inventionBronchodilator AgentsCrystallinityChemical engineeringlawDrug DiscoverySalbutamolmedicineAlbuterolParticle sizeCrystallizationMicronizationParticle SizePowdersCrystallizationmedicine.drugDrug development and industrial pharmacy
researchProduct

Preparation of white beeswax microspheres loaded with valproic acid and kinetic study of drug release

1995

AbstractThe well known antiepileptic valproic acid (1) due to the long treatment of epilepsy may induce many adverse side effects on various systems. To minimize unwanted toxic effects by kinetic control of drug release, 1 was physically entrapped into white beeswax microspheres using the meltable dispersion process utilizing wetting agents. Solid, discrete, reproducible free flowing microspheres were obtained converting the liquid drug droplets into solid material. The average drug content was 17% w/w. More than 95% of the isolated microspheres were of particle size range 200-425 µm. The microspheres were analyzed to quantify the amount of incorporated drug and to characterize the in vitro…

PharmacologyDrugActive ingredientValproic AcidChromatographyChemistrymedia_common.quotation_subjectOrganic ChemistryPharmaceutical SciencePharmacologyDosage formMicrosphereDrug DiscoverymedicineLiberationWettingParticle sizemedia_commonmedicine.drug
researchProduct

Determination of Phenylephrine Hydrochloride by Flow Injection Analysis with Chemiluminescence Detection

2001

Abstract A new method is proposed for the determination of phenylephrine hydrochloride by flow injection analysis with direct chemiluminescence detection. The method is based on the oxidation of the drug by potassium permanganate in sulfuric acid medium at 80°C. The calibration graph is linear over the range 0.03–8 ppm phenylephrine hydrochloride, with a relative standard deviation (n = 51, 0.5 ppm) of 1.1% and sample throughput of 134/h. The influence of 38 different foreign compounds was tested, and the method was applied to the determination of phenylephrine hydrochloride in 8 different pharmaceutical formulations.

PharmacologyFlow injection analysisChromatographyChemistryCalibration curveAnalytical chemistryPhenylephrine HydrochlorideDosage formAnalytical Chemistrylaw.inventionPotassium permanganatechemistry.chemical_compoundlawmedicineEnvironmental ChemistryAgronomy and Crop SciencePhenylephrineQuantitative analysis (chemistry)Food Sciencemedicine.drugChemiluminescenceJournal of AOAC INTERNATIONAL
researchProduct

Modelo predictivo preliminar para la identificación de pacientes con oportunidades de mejora farmacoterapéutica

2010

Objective: To develop a prediction model for identifying patients with the possibility of improving pharmacotherapy during the process of pharmaceutical validation of the prescription. Method: Cross-sectional study over two months, performed in the Internal Medicine and Infectious Disease divisions. Detecting opportunities for improving quality of pharmaco¬therapy is done by means of a pharmacist's validation of the prescription. Based on the information we obtained through this process, we performed a multivariate logistic regression analysis using as prognostic factors the demographic, pharmacotherapy and clinical variables related to identifying any drug-related problems (DRPs) in the pa…

PharmacologyGerontologymedicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationPharmacistArea under the curveLogistic regressionPharmacotherapyInternal medicinemedicineDosage adjustmentPredictive variablesMedical prescriptioneducationbusinessFarmacia Hospitalaria
researchProduct

In silicoprediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen

2012

The FDA Biopharmaceutical Classification System guidance allows waivers for in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms only for BCS class I. Extensions of the in vivo biowaiver for a number of drugs in BCS class III and BCS class II have been proposed, in particular, BCS class II weak acids. However, a discrepancy between the in vivo BE results and in vitro dissolution results for BCS class II acids was recently observed. The objectives of this study were to determine the oral absorption of BCS class II weak acids via simulation software and to determine if the in vitro dissolution test with various dissolution media could be sufficient …

PharmacologyKetoprofenChromatographyChemistryPharmaceutical ScienceGeneral MedicineBioequivalenceIbuprofenDosage formBioavailabilitymedicinePharmacology (medical)Dissolution testingSolubilityDissolutionmedicine.drugBiopharmaceutics & Drug Disposition
researchProduct

Carnauba wax microspheres loaded with valproic acid: Preparation and evaluation of drug release

1995

AbstractTo minimize unwanted toxic effects of valproic acid (1) by the kinetic control of drug release, gastroresistant carnauba wax microspheres loaded with the antiepileptic agent were prepared. The preparation was based on a technique involving melting and dispersion of drug-containing wax in an aqueous medium. The resulting emulsion after cooling under rapid stirring produced solid, discrete, reproducible free flowing microspheres which converted the liquid drug droplets into solid material. About 94% of the isolated microspheres were of particle size range 200-425 μm. The microspheres were analyzed to determine the drug content in various particle size range and to characterize the in …

PharmacologyWaxChromatographyOrganic ChemistryPharmaceutical ScienceDosage formMicrospherechemistry.chemical_compoundchemistryvisual_artDrug DiscoveryEmulsionvisual_art.visual_art_mediumLiberationParticle sizeCarnauba waxDispersion (chemistry)
researchProduct

In vivopredictive release methods for medicated chewing gums

2012

Understanding the performance of a drug product in vivo plays a key role in the development of meaningful in vitro drug release methodology. In case of functional chewing gums, the mode and the mechanism of release and the site of application differ significantly from other conventional solid oral dosage forms and require a special consideration to extract meaningful information from clinical studies. In the current study, suitable drug release methodology was developed to predict the in vivo performance of an investigated chewing gum product. Different parameters of the drug release testing apparatus described in the Ph. Eur. and Pharmeuropa were evaluated. Drug release data indicate that …

Pharmacologybusiness.industryPharmaceutical ScienceGeneral MedicinePharmacologyChewing gumDosage formIVIVCIn vivoDrug releaseDrug productMedicinePharmacology (medical)In vitro in vivobusinessRelease methodsBiopharmaceutics & Drug Disposition
researchProduct